Africa Molecular Diagnostics Market Size to Hike at 13.2% CAGR to 2026

Published Date: 2020-09-08

Request a sample

According to the Graphical Research new growth forecast report titled Africa Molecular Diagnostics Market Value is set to earn USD 839 million by 2026. Increasing prevalence of communicable diseases in developing economies of Africa has stimulated the demand for molecular diagnostics. For instance, low- and middle-income countries in Africa demonstrates a high burden of rotavirus disease. The environment is one of the prominent causes of the rising disease burden in Africa. It is a primary determinant of an individual’s and community’s health. The region has been affected by problems relating to access to safe drinking water, poor infrastructure and inadequate sanitation. Other contributors to the disease burden are perinatal conditions, chronic obstructive pulmonary disease (COPD), Tuberculosis, and HIV/AIDS, among others. Therefore, the aforementioned factors outline the rising necessity for effective care and proper diagnostics in the region that creates lucrative growth opportunities for the business participants to invest.

On the basis of application, the market is bifurcated into infectious disease, blood screening, genetic testing and oncology testing. The genetic testing segment accounted for around USD 23 million in 2019, due to its extensive array of applications and technological advancements. Genetic testing has evolved from niche specialty for rare disorders towards wide-ranging applications for complex diseases and personal use. Numerous applications including newborn screening, pre-symptomatic as well as predictive testing and pharmacogenetics testing among others prove beneficial for the segmental expansion. Moreover, the demand for genetic testing will keep on surging from primary care physicians to genetics specialists that will eventually boost the Africa molecular diagnostics market growth.

The technology segment of market is divided into PCR, chips and microarrays, in situ hybridization, sequencing, mass spectrometry, isothermal amplification and others. The PCR segment is estimated to witness more than 12.5% CAGR during the forecast period, as this technique is used for rapid recognition of pathogens. The Real-Time PCR (RT-PCR) has progressed as innovative technology and is continuously used in research laboratories and clinical diagnostics, as this technology is considered as an accurate and fast platform for the generation of quantitative and qualitative results. In addition, rising occurrence of genetic disorders and infectious diseases coupled with increased public and private investments for PCR-based research is supporting the segmental growth.

Furthermore, COVID-19 pandemic has impacted and stimulated demand for molecular diagnostics. With preference for less time-consuming molecular testing modalities and to avoid contamination during process, PCR technology will witness considerable demand.

Nigeria molecular diagnostics market is accounted for USD 23 million in 2019. Increasing government and non-government initiatives to raise awareness regarding HIV, tuberculosis and others among the population base for effective patient care will boost the country growth. For instance, AIDS Prevention Initiative in Nigeria (APIN) is a non-governmental donor-funded association devoted to the treatment, care and prevention of infectious diseases including STDs and HIV among others. Also, different associations in this country work towards effective patient management thereby, securing the overall market growth.

Few of the eminent market players operating in the Africa Molecular Diagnostics Market include Abbott Laboratories, Becton, Dickinson and Company, Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Analytik Jena, Bio-Techne, Celtic Molecular Diagnostics, Cleaver Scientific Ltd, Danaher Corporation, Roche, Hologic, Johnson & Johnson Services, Qiagen and Siemens Healthcare. The industry players to maintain their financial stability undertake several growth initiatives to maintain a strong market position. For instance, In March 2019, Abbott declared CE mark for Alinity M diagnostics systems and assays. This strategy helped the company to cope up with increasing demand of infectious disease testing.

Africa Molecular Diagnostics Market Research Report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:

Market Share, By Application, 2015 - 2026 (USD Million)

  • Infectious disease
    • Flu
    • RSV virus
    • Tuberculosis
    • Meningitis
    • HIV market
    • Hepatitis C
    • Hepatitis B
    • HPV
    • STD
      • Chalmydia
      • Gonorrhea
      • Others
    • Dengue
    • H.Pylori
    • TORCH
    • Others
  • Blood screening
  • Genetic testing
  • Oncology testing

Market Size, By Technology, 2015 - 2026 (USD Million)

  • PCR
  • In Situ Hybridization
  • Chips and microarrays
  • Mass spectrometry
  • Sequencing
  • Isothermal Amplification
  • Others

The above information is provided for the following region and countries:

  • Africa
    • Uganda
    • Kenya
    • Malawi
    • Tanzania
    • Nigeria
    • Ethiopia
    • Zimbabwe
    • Mozambique
    • Rwanda
    • South Africa
    • Cameroon
    • DRC
    • Others